News

Major US consumer group asks FDA to ban drug for diabetes

BMJ 2008; 337 doi: 10.1136/bmj.a2401 (Published 5 November 2008)
Cite this as: BMJ 2008;337:a2401

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Janice Hopkins Tanne
  1. 1New York

    Public Citizen, a US national consumer advocacy group, has petitioned the US Food and Drug Administration to ban the drug rosiglitazone (sold as Avandia), which is prescribed for type 2 diabetes.

    The group said that liver failure, often fatal, was a newly documented risk with the drug, which is made by GlaxoSmithKline. Previously the drug had been linked to an increased risk of heart attacks, heart failure, bone fractures, and eye problems, Public Citizen said.

    The drug now carries a “black box” warning from the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular